Evolus posts quarterly profit on strong sales of cosmetic injection
March 4 (Reuters) - Cosmetic drugmaker Evolus EOLS.O reported a fourth-quarter profit versus a year-ago loss on Tuesday, on strong demand for its wrinkle treatment Jeuveau which competes with Botox.
WHY IT'S IMPORTANT
The company has been targeting a younger demographic compared to other companies such as Revance and AbbVie ABBV.N, among others, which typically focus on people in their 40s.
In February, the U.S. FDA approved Evolus' two new dermal fillers - Evolysse Form and Evolysse Smooth - which are expected to contribute 8%-10% to its total revenue for 2025.
KEY QUOTE
"We are prepared to launch Evolysse in the second quarter and will be making significant investments in medical education and sampling to support our customers and drive adoption," said CEO David Moatazedi.
BY THE NUMBERS
Evolus reported an adjusted income of $6.7 million in the fourth quarter, compared with a year-ago loss of $3.7 million.
The company sees 2025 revenue between $345 million and $355 million, compared with Wall Street estimates of $351.3 million according to data compiled by LSEG.
The company projects its annual net revenue can reach at least $700 million by 2028.
Related Articles
Coca Cola (KO) Q4 Earnings Preview: Look for the Upside in the AI Initiatives, not in the Revenue and the EPS
Coca-Cola (KO) enters its fourth-quarter 2025 earnings call tomorrow with significant momentum. However, a fundamental shift is occurring.
Warsh’s Fed Era Signals a Death Knell for QE, Jolting the $30 Trillion Treasury Market
With Warsh’s nomination, his past proposals for governing the Federal Reserve are being brought to the forefront. A central issue is the formulation of a new "1951 Accord" to restructure the relationship between the Fed and the Treasury. Analysts suggest such a move could impact the $30 trillion Tre
Amazon Stock Predictions for 2026 to 2030: Will They Exceed Expectations and Achieve Major Long-Term Goals?
TradingKey - As we head into 2026, many investors are questioning where Amazon (AMZN) fits into the technology world.
A Crash After a Surge: Why Silver Lost 40% in a Week?
TradingKey - Spot silver (XAGUSD) prices continue to decline. Silver plunged 20% on Thursday, breaking below $71 per ounce, with the sell-off intensifying on Friday as prices fell further below $64. Compared to the all-time high set on January 29, silver prices have retraced more than 40%, wiping out nearly all gains accumulated over the previous month.
